To verify the effect of miR-497/SK-NBs on ICD at the tumor site, we performed immunofluorescent (Figure 5A), flow cytometer (Figure 5B) and ELISA (Figures 5E, F) to evaluate the density of CRT and HMGB1 in tumor masses. The gene discussed is HMGB1; the disease is neoplasm.